Skip to main content

We've updated our Privacy Policy. Questions? Email us any time at privacy@ground.news

SubscribeLogin
Published • loading... • Updated

ProKidney reports larger second-quarter loss

Summary by Winston-Salem Journal
ProKidney Corp.'s ramping up of pivotal clinical trials for potential breakthrough drug therapies contributed to a larger second-quarter loss for the Winston-Salem biopharmaceutical manufacturer.

1 Articles

Winston-Salem JournalWinston-Salem Journal
Lean Left

ProKidney reports larger second-quarter loss

ProKidney Corp.'s ramping up of pivotal clinical trials for potential breakthrough drug therapies contributed to a larger second-quarter loss for the Winston-Salem biopharmaceutical manufacturer.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Winston-Salem Journal broke the news on Sunday, August 16, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Winston-Salem icon

Winston-Salem

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal